More than six years after emergency powers transformed America’s healthcare system during the COVID-19 pandemic, the U.S. Department of Health and Human Services (HHS) has announced the formal end of emergency use authorization (EUA) declarations for COVID-19 drugs, biological products, and medical devices.
The decision, signed by Health and Human Services Secretary Robert F. Kennedy Jr., signals what many see as the final regulatory chapter of the pandemic era and a return to traditional FDA oversight.
Emergency Powers Begin to Sunset
HHS announced that the emergency declarations originally issued in 2020 are no longer justified because the conditions that created the COVID-19 emergency have substantially changed.
The declarations allowed the Food and Drug Administration (FDA) to rapidly authorize vaccines, treatments, diagnostic tests, ventilators, and other medical products through Emergency Use Authorizations rather than the traditional approval process.
Secretary Kennedy stated:
“Americans deserve a regulatory system that is transparent, accountable, and rooted in the rule of law. By ending these COVID-19 emergency use authorization declarations, we’re reinforcing public confidence that emergency authorities are temporary and targeted.”
The move follows years of debate over how long emergency powers should remain in place after the federal public health emergency officially ended in 2023.
Important Transition Dates
Rather than ending immediately, HHS established phased expiration dates to allow manufacturers and healthcare providers time to transition.
Medical Devices
Emergency declarations for medical devices will expire:
December 26, 2026
(180 days after the announcement)
Drugs and Biological Products
Emergency declarations covering drugs and biological products will expire:
June 29, 2027
(One year following the Secretary’s determination)
The transition period is intended to provide hospitals, physicians, manufacturers, distributors, and patients adequate time to move products onto traditional FDA approval pathways.
Why HHS Says Emergency Powers Are No Longer Necessary
According to HHS, several factors influenced the decision.
Among them:
- Fully FDA-approved COVID-19 treatments are now widely available.
- Healthcare providers have years of clinical experience managing COVID-19.
- Manufacturers have had ample opportunity to pursue traditional FDA approval.
- Reliance on emergency-authorized products has steadily declined.
- The national public health emergency officially ended several years ago.
Federal officials emphasized that emergency authorities were never intended to become permanent regulatory tools.
Instead, they were designed for extraordinary public health crises.
What Happens Next?
The FDA will continue working directly with manufacturers seeking:
- Full FDA Approval
- FDA Clearance
- Product Licensure
Products currently operating solely under Emergency Use Authorization must either successfully complete those regulatory processes or eventually leave the marketplace once their authorization expires.
Hospitals and healthcare systems are now being encouraged to review their inventories and determine which products remain under EUA status.
Impact on Hospitals and Healthcare Providers
Healthcare organizations are expected to begin preparing immediately.
Industry experts recommend providers:
- Audit current COVID-19 medications and devices.
- Verify regulatory status with manufacturers.
- Update clinical protocols.
- Train staff on upcoming changes.
- Identify FDA-approved replacement products when necessary.
Medical devices face the earliest deadline, making them the immediate priority for hospital compliance departments.
Broader Policy Implications
The announcement represents another significant shift under Secretary Kennedy’s leadership at HHS.
Supporters argue the move restores regulatory accountability and reinforces that emergency powers should remain temporary rather than evolving into long-term governance.
Critics, however, caution that healthcare providers must carefully manage the transition to avoid disruptions in patient care or supply chains.
The decision is also expected to influence future debates over executive emergency powers, public health policy, and federal regulatory authority.
What Products Could Be Affected?
Products potentially impacted include:
- COVID-19 therapeutics still operating under EUA
- Certain biological products
- Diagnostic equipment authorized only through emergency declarations
- Medical devices that have not yet received full FDA approval
Many COVID-19 vaccines, medications, and diagnostic tools have already completed traditional FDA approval processes and will not be affected.
Healthcare providers are encouraged to verify each product individually rather than assuming its regulatory status.
Congress Will Be Notified
HHS confirmed it will:
- Publish termination notices in the Federal Register
- Notify Congress as required by law
- Continue coordinating with manufacturers during the transition period
The department emphasized that patient access and healthcare continuity remain priorities throughout the process.
News Watchmen Prophetic Perspective
The COVID-19 pandemic dramatically expanded government authority over healthcare, commerce, education, travel, and daily life in ways few Americans had previously experienced.
While opinions differ on the policies adopted during the pandemic, Scripture repeatedly reminds believers to exercise wisdom, discernment, and faith during times of uncertainty.
Jesus warned that difficult seasons would come before His return, encouraging His followers to remain steadfast rather than fearful (Matthew 24:4–14). Likewise, believers are called to “test everything; hold fast what is good” (1 Thessalonians 5:21), carefully evaluating information and decisions in light of truth.
As emergency authorities continue to wind down, many Christians see this moment as an opportunity to reflect on the balance between public safety, governmental authority, individual liberty, and personal responsibility.
Frequently Asked Questions
When do the medical device emergency authorizations end?
Medical device EUA declarations expire on December 26, 2026.
When do emergency authorizations for COVID-19 drugs end?
The declarations for drugs and biological products expire on June 29, 2027.
Does this affect all COVID-19 vaccines and treatments?
No. Many COVID-19 products already have full FDA approval and are not affected by these EUA declaration terminations.
Why is HHS ending the emergency declarations?
HHS says the public health conditions that justified emergency authorizations no longer exist and that traditional FDA regulatory pathways are now appropriate.
What should hospitals do now?
Hospitals should review inventories, verify the approval status of COVID-19 products, communicate changes to staff, and prepare for the transition to fully approved alternatives where necessary.
After much research, the following supplements can prevent Covid and other viruses. My family and I mainly follow the protocol of Dr Bryan Ardis. This is only my opinion based on my own family’s success. Please make sure you do your own research and speak with your medical professional before making any changes to your health routine.
EDTA
Glutathion
NAC
Zinc
Vitamin C (Ascorbic Acid)
Vitamin D3
Quercetin
Cats Claw
Nicotine
Bromelain
Curcumin
Dr. McCullough recommends taking this treatment triad for at least three months for anyone suffering from or worried about post-COVID or post-vaccine syndromes.
Nattokinase, Bromelain, and Curcumin are available over the counter at just about any health food store or pharmacy.
Selenium
Dandelion Root
Black Sativa Extract (may facilitate cellular repair)
Green Tea Extract (provides added defenses at the cellular level through scavenging for free radicals)
Irish Sea Moss (could help rebuild damaged tissue and muscle)
In an acute emergency, if you get Covid, Dr Ardis suggests taking low doses of Nicotine in the form of Lozenges, Gum, or Patches for a few days until symptoms subside
Affiliate Disclosure:
Some links in my articles may bring me a small commission at no extra cost to you. Thank you for your support of my work here!
News Watchmen 
Leave a comment